# Retrorsine impairs liver regeneration by inducing progenitor cell-senescence via ROS after partial hepatectomy

**Authors:** Yan Cui, Li Li, Yu He, Shan Shan, Lin Liu, Jiangbo Ren, Hui Wang, Miaoran Yang, Xinyan Zhao, Jidong Jia, Ping Wang

PMC · DOI: 10.1080/07853890.2026.2635821 · 2026-03-03

## TL;DR

Retrorsine stops liver regeneration by causing liver progenitor cells to age, even when liver cells can't reproduce.

## Contribution

Shows that Retrorsine causes progenitor cell aging via ROS, limiting liver regeneration when hepatocytes are inactive.

## Key findings

- Retrorsine suppresses hepatocyte proliferation in a dose-dependent manner.
- HPCs show minimal regeneration contribution when hepatocyte proliferation is fully blocked.
- Retrorsine induces HPC senescence through increased ROS and DNA damage markers.

## Abstract

Hepatic progenitor cells (HPCs) provide an alternative regenerative pathway when hepatocytes are in a senescent state or after chronic liver injury. Yet, their contribution to liver regeneration after partial hepatectomy (PH) remains controversial. The aim of this study is to reveal the regeneration contribution of HPCs after PH when hepatocyte proliferation is totally suppressed.

Retrorsine (RTS) was administered to suppress hepatocyte proliferation in C57BL/6J mice after PH. The regeneration contribution of HPCs was assessed using HPC-specific lineage tracing mice (Sox9Cre-ERRosatdTomato) after RTS/PH. The effects of RTS on HPCs were analyzed by HPC-enriched organoids in vitro.

RTS 0–70 mg/kg dose-dependently reduced the PCNA+ hepatocyte ratio on day 2 post-PH with hepatocyte proliferation completely suppressed by 70 mg/kg RTS. Yet, the proportion of PCNA+ HPCs did not increase in these 70 mg/kg RTS/PH mice, suggesting that HPCs were not activated when RTS completely inhibited hepatocyte proliferation. By day 14 post-PH, the 70 mg/kg RTS/PH mice exhibited reduced liver-to-body weight ratios compared to control mice, indicating regeneration failureafter PH. Simultaneously, the tdTomato-positive regenerative foci derived from labeled HPCs were not significantly different from those of the controls, indicating a minimal regeneration contribution from HPCs. RTS increased intracellular ROS levels and β-galactosidase activity of HPC-enriched liver oranoids in vitro, and phospho-H2A.X positive HPCs could be found in 70 mg/kg RTS/PH mouse liver, suggesting RTS-induced HPC senescence.

When hepatocyte proliferation was completely suppressed by RTS, HPCs contributed minimally to liver regeneration owing to cellular senescence, resulting in regeneration failure.

HPCs contribute minimally to liver regeneration when hepatocyte proliferation is completely arrested by RTS, leading to liver recovery failure.RTS targets HPCs in the liver, in addition to hepatocytes and sinusoidal endothelial cells, and induces HPC senescence via ROS generation.RTS-induced regeneration failure was accompanied by hepatocyte hypertrophy and CD11b+Ly6G+ MDSC infiltration.

HPCs contribute minimally to liver regeneration when hepatocyte proliferation is completely arrested by RTS, leading to liver recovery failure.

RTS targets HPCs in the liver, in addition to hepatocytes and sinusoidal endothelial cells, and induces HPC senescence via ROS generation.

RTS-induced regeneration failure was accompanied by hepatocyte hypertrophy and CD11b+Ly6G+ MDSC infiltration.

## Linked entities

- **Proteins:** PCNA (proliferating cell nuclear antigen), ITGAM (integrin subunit alpha M), Ly6g (lymphocyte antigen 6 family member G)
- **Chemicals:** Retrorsine (PubChem CID 5281743)

## Full-text entities

- **Genes:** H2ax (H2A.X variant histone) [NCBI Gene 15270] {aka H2A.X, H2afx, Hist5-2ax, gammaH2ax}, Cdkn1a (cyclin dependent kinase inhibitor 1A) [NCBI Gene 12575] {aka CAP20, CDKI, CIP1, Cdkn1, P21, SDI1}, D9Mgc45e (DNA segment, Chr 9, MRC UK Mouse Genome Centre 45 expressed) [NCBI Gene 28134] {aka CD3}, Mul1 (mitochondrial ubiquitin ligase activator of NFKB 1) [NCBI Gene 68350] {aka 0610009K11Rik, Gide, Tnrip-1}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Tnfsf18 (tumor necrosis factor (ligand) superfamily, member 18) [NCBI Gene 240873] {aka Gitrl, Tnlg2a}, Skp2 (S-phase kinase-associated protein 2) [NCBI Gene 27401] {aka 4930500A04Rik, FBXL1, FWD1, p45}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Glb1 (galactosidase, beta 1) [NCBI Gene 12091] {aka Bge, Bgl, Bgl-e, Bgl-s, Bgl-t, Bgs}, Stat3 (signal transducer and activator of transcription 3) [NCBI Gene 20848] {aka 1110034C02Rik, Aprf}, Itgam (integrin alpha M) [NCBI Gene 16409] {aka CD11b/CD18, CR3, CR3A, Cd11b, F730045J24Rik, Ly-40}, Gpt (glutamic pyruvic transaminase, soluble) [NCBI Gene 76282] {aka 1300007J06Rik, 2310022B03Rik, ALT, ALT1, Gpt-1, Gpt1}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, ITGAM (integrin subunit alpha M) [NCBI Gene 3684] {aka CD11B, CR3A, HNA-4, MAC-1, MAC1A, MO1A}, Pcna (proliferating cell nuclear antigen) [NCBI Gene 18538], Hmga1 (high mobility group AT-hook 1) [NCBI Gene 15361] {aka Hmga1a, Hmga1b, Hmgi, Hmgiy, Hmgy}, Hc (hemolytic complement) [NCBI Gene 15139] {aka C5, C5a, He, Hfib2}, Marco (macrophage receptor with collagenous structure) [NCBI Gene 17167] {aka Ly112, Scara2}, Sox9 (SRY (sex determining region Y)-box 9) [NCBI Gene 20682] {aka 2010306G03Rik, mKIAA4243, mSox9}, Hnf4a (hepatic nuclear factor 4, alpha) [NCBI Gene 15378] {aka HNF-4, Hnf4, Hnf4alpha, MODY1, Nr2a1, TCF-14}, Pdk1 (pyruvate dehydrogenase kinase, isoenzyme 1) [NCBI Gene 228026] {aka B830012B01, D530020C15Rik}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Tmprss11d (transmembrane protease, serine 11d) [NCBI Gene 231382] {aka AST, AsP}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, Dpp4 (dipeptidylpeptidase 4) [NCBI Gene 13482] {aka Cd26, Dpp-4, THAM}, Mdm2 (MDM2 proto-oncogene) [NCBI Gene 17246] {aka 1700007J15Rik, Mdm-2}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}
- **Diseases:** HPCs (MESH:D006528), dislocation (MESH:D004204), hepatocyte damage (MESH:D020263), PH (MESH:D004828), chronic liver injury (MESH:D056487), liver toxicity (MESH:D056486), liver (MESH:D017093), AAF (MESH:D020803), regeneration failure (MESH:D051437), hypertrophy (MESH:D006984), toxicity (MESH:D064420), liver fibrosis (MESH:D008103), injuries (MESH:D014947), deaths (MESH:D003643), blood (MESH:D006402)
- **Chemicals:** PBS (MESH:D007854), HCl (MESH:D006851), ROS (MESH:D017382), NaOH (MESH:D012972), water (MESH:D014867), CO2 (MESH:D002245), RS (MESH:D000084922), DCFH-DA (MESH:C029569), RTS (MESH:C003300), TRIzol (MESH:C411644), tamoxifen (MESH:D013629), corn oil (MESH:D003314), Cy5.5 (MESH:C098793), 2-acetylaminofluorene (MESH:D015073), MTT (MESH:C070243), F12 (MESH:C007782), pentobarbital sodium (MESH:D010424), Cy7 (-), NaCl (MESH:D012965), pyrrolizidine alkaloid (MESH:D011763), Alexa Fluor 647 (MESH:C569686)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** HepaRG — Homo sapiens (Human), Hepatitis C infection, Cancer cell line (CVCL_9720), H2.35 — Mus musculus (Mouse), Transformed cell line (CVCL_4210), C57B/6J — Mus musculus (Mouse), Finite cell line (CVCL_A9HH), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW)

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12961708/full.md

---
Source: https://tomesphere.com/paper/PMC12961708